Close association between oral Candida species and oral mucosal disorders in patients with xerostomia

Oral Diseases

Volumn 18, Issue 7, 2012, Pages 667-672

  Shinozaki, S ^a   Moriyama, M ^a   Hayashida, J N ^a   Tanaka, A ^a   Maehara, T ^a   Ieda, S ^a   Nakamura, S ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Candida; Oral candidiasis; Xerostomia

Indexed keywords

ADULT; AGED; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLOW RATE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; MALE; NONHUMAN; ORAL MUCOSAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SALIVA; THRUSH; TONGUE; XEROSTOMIA;

ADULT; AGED; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS, ORAL; CASE-CONTROL STUDIES; CHEILITIS; CHI-SQUARE DISTRIBUTION; COLONY COUNT, MICROBIAL; DNA, FUNGAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SALIVA; SJOGREN'S SYNDROME; STATISTICS, NONPARAMETRIC; TONGUE DISEASES; XEROSTOMIA;

EID: 84866296498     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2012.01923.x     Document Type: Article

References (39)

1. Abu-Elteen KH, Abu-Alteen RM (1998). The prevalence of C. albicans populations in the mouths of complete denture wearers. Microbiologica 21: 41-48.
2. Astor FC, Hanft KL, Ciocon JO (1999). Xerostomia: a prevalent condition in the elderly. Ear Nose Throat J 78: 476-479.
3. Bahn SL, Conn WH (1972). Drug-related dental destruction. Oral Surg 33: 49-54.
4. Borg-von Zepelin M, Eiffert H, Kann M, Ruchel R (1993). Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Gottingen, Germany. Mycoses 36: 247-253.
5. Cormack BP, Ghori N, Falkow S (1999). An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 285: 578-582.
6. Dickson RC (1997). Clinical manifestations of hepatitis C. Clin Liver Dis 1: 568-585.
7. Epstein JB, Chow AW (1999). Oral complications associated with immunosuppression and cancer therapies. Infect Dis Clin North Am 13: 901-923.
8. Epstein JB, Truelove EL, Izutzu KT (1984). Oral candidiasis: pathogenesis and host defense. Rev Infect Dis 6: 96-106.
9. Ettinger RL (1981). Xerostomia-a complication of ageing. Aust Dent J 26: 365-371.
10. Fidel PL Jr, Vazquez JA, Sobel JD (1999). Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 12: 80-96.
11. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K (2004). Revised Japanese criteria for Sjögren's syndrome (1999):availability and validity. Mod Rheumatol 14: 425-434.
12. Janket SJ, Jones JA, Rich S, Meurman J, Garcia R, Miller D (2003). Xerostomic medications and oral health: the Veterans Dental Study. Gerodontology 20: 41-49.
13. Klotz SA (1994). The contribution of electrostatic to the process of adherence of C. albicans yeast cell to substrates. FEMS Microbiol Lett 120: 257-262.
14. Kohler PF, Winter ME (1985). A quantitative test for xerostomia: the Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 28: 1128-1132.
15. Lockhart PB, Clark JR (1990). Oral complications following neoadjuvant chemotherapy in patients with head and neck cancer. NCI Monogr 9: 99-101.
16. Maderzazo EG, Jameson JM (2002). Infections and the host. In: Topazian RG, Goldberg MH, Hupp JR, eds. Oral and maxillofacial infections. 4th edn. WB Saunders: Philadelphia, PA, pp. 1-29.
17. Mathews MS, Samuel PR, Suresh M (2001). Emergence of Candida tropitcalis as the major cause of fungaemia in India. Mycoses 44: 278-280.
18. McCreight MC, Warnock DW, Watkinson AC (1984). Prevalence of different strains of C. albicans in patient with dentureinduced Stornatitis. J Med Veter Myc 1(22): 83-85.
19. Mirhendi H, Makimura K, Khoramizadeh M, Yamaguchi H (2006). A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Nippon Ishinkin Gakkai Zasshi 47: 225-229.
20. Moskona D, Ilana K (1992). Oral lesions in elderly denture wearers. Clin Prevent Dent 14: 11-14.
21. Navazesh M, Ship II (1983). Xerostomia: diagnosis and treatment. Am J Otolaryngol 4: 283-292.
22. Navazesh M, Wood G, Brightman VJ (1995). Relationship between salivary flow rates and Candida albicans counts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80: 284-288.
23. Nguyen MH, Peacock JE Jr, Morris AJ et al (1996). The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 100: 617-623.
24. Nishiyama Y, Nakaoka C, Hiratani T, Abe S, Uchida K, Yamaguchi H (2001). Synergy of lysozyme and lanoconazole on the morphology of C. albicans. J Electron Microscopy 50: 41-49.
25. Pfaliler MA, Houston A, Coffrnann S (1996). Application of CHROMagar for rapid screening of clinical specimens for C. albicans, C. tropicalis C. krusei, C. glabrata. J Clin Microbiol 34: 58-61.
26. Radfar L, Shea Y, Fischer SH et al (2003). Fungal load and candidiasis in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 283-287.
27. Rhodus NL, Bloomquist C, Liljemark W, Bereuter J (1977). Prevalence, density, and manifestations of oral Candida albicans in patients with Sjögren's syndrome. J Otolaryngol 26: 300-305.
28. Samaranayake YH, Samaranayake LP (1994). Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J Med Microbiol 41: 295-310.
29. Schall GL, Larson SM, Anderson LG, Griffith JM (1972). Quantification of parotid gland uptake of pertechnetate using a gamma scintillation camera and a "region-of-interest" system. Am J Roentgenol Radium Ther Nucl Med 115: 689-697.
30. Shimizu C, Kuriyama T, Williams DW et al (2008). Association of oral yeast carriage with specific host factors and altered mouth sensation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105: 445-451.
31. Silverman S Jr (1999). Oral cancer: complications of therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88: 284-288.
32. Skopouli FN, Siouna-Fatourou HI, Ziciadis C, Moutsopoulos HM (1989). Evaluation of unstimulated whole saliva flow rate and stimulated parotid flow as confirmatory tests for xerostomia. Clin Exp Rheumatol 7: 127-129.
33. Spielman A, Ben-Aryeh H, Gutman D, Szargel R, Deutsch E (1981). Xerostomia-diagnosis and treatment. Oral Surg 51: 144-147.
34. Sreebny LM (1990). Salivary flow in health and disease. Compend Contin Educ Dent 13: 461-469.
35. Tatal N, Moutsopoulos HM, Kassan SS (1978). Sjögren's syndrome - clinical and immunological aspects. Springer-Verlag: Berlin.
36. Tenovuo J, Lumikari M, Soukka T (1991). Salivary lysozyme, lactoferrin and peroxidases: antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry. Proc Finn Dent Soc 87: 197-208.
37. Vennewald I, Seebacher C, Roitzsch E (1998). Post-mortem findings in patients with repeatedly mycological demonstration of Candida glabrata. Mycoses 41: 125-132.
38. Vitali C, Bombardieri S, Moutsopoulos HM et al (1993). Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 36: 340-347.
39. Vitali C, Bombardieri S, Jonsson R et al (2002). European Study Group on classification criteria for Sjögren's syndrome. Classification criteria for Sjögren's syndrome- a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-558.